Hemostemix Inc shows modest gains this week amidst a quiet news backdrop.
This week, Hemostemix Inc (HEM.V) has experienced an 8.33% rise in its stock price, closing at C$0.07. Despite this uptick, the company's year-to-date performance remains negative, down 27.78%. Let's delve into the latest developments and the technical landscape surrounding Hemostemix.
Advertisement
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeMarket cap
$13.74M
52W high
$0.11
52W low
$0.04
1W change
+8.33%
Beta
0.73
Analyst Price Targets
Based on analyst covering HEM · as of Sep 17, 2026
Wall Street analysts forecast HEM stock price to rise 1376.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1376.9% Upside
Current Price
C$0.07
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
79.2%
Annualized
90-Day Vol
110.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.05 – C$0.09 |
| 60 trading days | C$0.07 | C$0.05 – C$0.11 |
| 90 trading days | C$0.08 | C$0.05 – C$0.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While Hemostemix has shown a recent upward trend, investors should remain cautious given the lack of significant news and the substantial decline in share price over the year.
8.33% Weekly Gain
Despite a weekly gain, Hemostemix's stock has seen a significant decline of 27.78% year-to-date, raising concerns about long-term viability.
Bull case
Analysts are optimistic about Hemostemix, with an average price target of C$0.96. This suggests there’s strong potential for the stock to rise if the company can effectively leverage its growth opportunities in the health care sector.
Bear case
On the downside, Hemostemix faces financial challenges, as indicated by its negative earnings per share and zero profit margin. These factors could discourage investors seeking stability.
Weekly Price Action
Hemostemix Inc (HEM.V) has experienced a positive week, with the stock price increasing by 8.33% to close at C$0.07. This modest gain comes after a period of volatility, as the stock has seen a decline of 13.33% over the past month.
Technical Picture
Advertisement
The technical indicators for Hemostemix reflect a stable position, with the 50-day moving average at C$0.07, which is 8.9% above the current price, and the 200-day moving average also at C$0.07, indicating a similar trend. The stock is trading within its 52-week range of C$0.04 to C$0.11, currently at 50% of that range. With a beta of 0.73, the stock has shown less volatility compared to the broader market, and current trading volume stands at 11,777 shares, which is 0.28 times the 20-day average volume of 24,895 shares.
Insider Activity
No recent insider trading activity has been reported for Hemostemix Inc, which may indicate a level of stability in management's outlook.
Analyst Outlook
Analysts maintain a bullish outlook for Hemostemix, with an average price target of C$0.96, suggesting an impressive implied upside of 1180%. This optimistic view stems from the company's potential in the health care sector, despite its current financial challenges.
Conclusion
Hemostemix Inc closed at C$0.07, unchanged from the previous day. While the stock has seen a notable weekly gain, investors should weigh the company's long-term performance and financial health before making investment decisions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
